Neurogene and Neoleukin announce definitive merger agreement EP News Bureau Jul 20, 2023 Upon completion of the merger, which is subject to approval by Neurogene and Neoleukin stockholders, the combined company is…
Eli Lilly announces Institute for Genetic Medicine and $700 million investment in Boston Seaport… EP News Bureau Feb 24, 2022 The facility will headquarter research efforts in Boston and New York to accelerate the development of RNA and DNA-based medicines
